Mirtazapine Tablet
Product Images NDC 71610-713

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71610-713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 30 mg (71610 0713 15)

Mirtazapine 30 mg tablets label by Aphena Pharma Solutions - Tennessee, LLC. The label states the product is Mirtazapine, USP, with a package count of 15 tablets. It includes storage instructions to keep the medication between 20-25°C and to protect from light and moisture. The NDC number is 71610-0713-15. The label also contains a barcode, batch number, and expiration date fields.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

Chemical structure of the active ingredient Mirtazapine, showing its bicyclic heterocyclic compound with nitrogen atoms and a methyl group attached to a nitrogen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.